RESUMO
Accurate assessment of the HER2 expression is an essential issue for predicting response to anti-HER2 therapy in breast cancer patients. The aim of this study was to evaluate 99mTc-HYNIC-(Ser)3-LTVPWY (99mTc-HYNIC-LY) peptide as a novel HER2-targeted radiolabeled peptide in healthy mice to examine the applicability of this imaging agent in a first-in-human clinical trial. To this end, pharmacokinetic and dosimetry studies were performed according to the ICH guideline M3 (R2) with 99mTc-HYNIC-LY. To estimate the radiation-absorbed doses in humans, the accumulated activity in each mouse organ was calculated based on biodistribution data. In addition, toxicology assessment was performed based on mortality events, body weights, and serum biochemical, hematological, and histopathological assays. The pharmacokinetic study showed rapid blood clearance. Based on the results of biodistribution study, the highest radioactivity was observed in the kidneys. The projected absorbed doses to the kidneys, liver, lungs, stomach, and spleen were obtained as 1.70E-02, 1.42E-02, 1.02E-02, 8.62E-03, and 8.34E-03 mSv/MBq, respectively. The results also revealed that serum biochemical and hematological parameters were in the normal range. No significant morphologic alterations were observed in the liver, kidneys, and spleen tissues. Consequently, the results were indicative of the suitability of 99mTc-HYNIC-LY peptide for advancement to a first-in-human clinical trial.
Assuntos
Compostos de Organotecnécio/farmacocinética , Peptídeos/farmacocinética , Compostos Radiofarmacêuticos/farmacocinética , Receptor ErbB-2/antagonistas & inibidores , Administração Intravenosa , Animais , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Compostos de Organotecnécio/sangue , Peptídeos/sangue , Radiometria , Compostos Radiofarmacêuticos/sangue , Receptor ErbB-2/metabolismo , Distribuição TecidualRESUMO
Heart imaging radiopharmaceuticals could improve the diagnostic value of routine heart scanning for detecting cardiac disorders. The aim of the study was to prepare high radiochemical purity 99mTc-Digoxin in a yield of about 98%. The optimal conditions for labelling were as follows: 100µg of Digoxin, 2µg of SnCl
Assuntos
Coração/diagnóstico por imagem , Compostos de Organotecnécio/síntese química , Compostos de Organotecnécio/farmacocinética , Cintilografia/métodos , Compostos Radiofarmacêuticos/síntese química , Compostos Radiofarmacêuticos/farmacocinética , Animais , Estabilidade de Medicamentos , Humanos , Camundongos , Miocárdio/metabolismo , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/química , Coelhos , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/química , Compostos de Estanho/química , Distribuição TecidualRESUMO
A new triazole oxotechnetium chelating agent was synthesized via a 'Click-to-Chelate' strategy. In vivo evaluation of the corresponding (99m)Tc complex shows that the tracer exhibits very interesting properties for molecular imaging.
Assuntos
Quelantes , Imagem Molecular , Compostos de Organotecnécio , Triazóis/síntese química , Animais , Quelantes/síntese química , Quelantes/química , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Estrutura Molecular , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/síntese química , Distribuição Tecidual , Triazóis/químicaRESUMO
Multivalent RGD peptides have been used as an excellent targeting vector to integrin αvß3-positive tumors. However, little attention has been paid to the influence of linker molecules in multivalent RGD peptides on their dissociation kinetics from tumor cells. In this study, we evaluated the dissociation kinetics of 99mTc-labeled hexavalent RGD peptides which have (CH2-CH2-O)n (n = 4, [99mTc][Tc(L1)6]+ and n = 12, [99mTc][Tc(L2)6]+) or (DPro-Gly)n (n = 1, [99mTc][Tc(L3)6]+; n = 6, [99mTc][Tc(L4)6]+; and n = 9, [99mTc][Tc(L5)6]+) as a linker molecule. The results showed that [99mTc][Tc(L4)6]+ and [99mTc][Tc(L5)6]+ displayed slower dissociation kinetics and [99mTc][Tc(L4)6]+ showed exceptionally high in vitro cellular uptake (203.1 ± 16.7% dose/mg protein) and the highest tumor to blood ratio (138.1 ± 26.3 at 4 h p.i.) in tumor bearing nude mice. These findings indicate that the use of appropriate length of (DPro-Gly)n would maximize the binding of multivalent RGD peptides to clustered integrin αvß3.
Assuntos
Integrina alfaVbeta3/metabolismo , Neoplasias/metabolismo , Oligopeptídeos/metabolismo , Animais , Linhagem Celular Tumoral , Humanos , Concentração Inibidora 50 , Cinética , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Oligopeptídeos/farmacocinética , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/farmacocinética , Ligação Proteica , Distribuição Tecidual , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
OBJECTIVES: To study the pharmacokinetics, biodistribution, and injection doses of 99mTc-TRODAT-1 in healthy adults. METHODS: Thirty healthy individuals comprising 15 females and 15 males were randomly divided into three groups and the injection doses of 99mTc-TRODAT-1 of group 1, 2, and 3 were 370 MBq, 740 MBq, and 1110 MBq, respectively. Assessments of subjective symptoms and tests were performed before and after injection. Blood and urine collections and whole-body planar imaging were analyzed at various time points. Bilateral brain striatal SPECT images obtained at 3.5 h PI were assessed visually and semiquantitatively. RESULTS: No serious adverse events or deaths were observed in our study. The pharmacokinetic analysis showed that 99mTc-TRODAT-1 was eliminated rapidly from the circulation, with just about 4% of the injected dose remaining in blood at 1 h post-injection. The mean cumulative urinary excretion over 24 h was just 2.96 ± 0.96%ID. The time-activity curve demonstrated that the radioactivity was mainly in liver and abdomen. The highest absorbed dose was in the dose-limiting organ, liver (20.88 ± 4.45 × 10-3 mSv/MBq). The average effective dose was 5.22 ± 1.05 × 10-3 mSv/MBq. The clarity of striatal images assessed visually in group 1 was worse than that in group 2 and 3. The semiquantitative analysis showed that there were no differences in striatum/cerebellum between the three groups (group 1: 1.77 ± 0.11, group 2: 1.62 ± 0.14, and group 3: 1.75 ± 0.20; P = 0.088). CONCLUSIONS: 99mTc-TRODAT-1 was safe to use in humans and showed the status of dopaminergic neurons specifically and clearly. The injection dose we suggested was 740 MBq.
Assuntos
Cerebelo/diagnóstico por imagem , Corpo Estriado/diagnóstico por imagem , Compostos de Organotecnécio/farmacocinética , Compostos Radiofarmacêuticos/farmacocinética , Tropanos/farmacocinética , Abdome , Adulto , Segurança Química , Neurônios Dopaminérgicos/metabolismo , Relação Dose-Resposta à Radiação , Feminino , Humanos , Fígado , Masculino , Especificidade de Órgãos , Compostos de Organotecnécio/administração & dosagem , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/urina , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/urina , Distribuição Tecidual , Tropanos/administração & dosagem , Tropanos/sangue , Tropanos/urina , Imagem Corporal TotalRESUMO
The ciprofloxacin dithiocarbamate (CPFXDTC) was synthesized and radiolabeled with [(99m)TcN](2+) intermediate to form the (99m)TcN-CPFXDTC complex in high yield (>95%). No decomposition of the complex at room temperature was observed over a period of 6 h. Its partition coefficient indicated that it was a good lipophilic complex. The bacterial binding assay studies showed (99m)TcN-CPFXDTC had a better binding affinity as compared with (99m)Tc-ciprofloxacin. Biodistribution results in induced infection mice showed (99m)TcN-CPFXDTC had higher uptake at the sites of infection and better abscess/blood ratio than that of (99m)Tc-ciprofloxacin, suggesting (99m)TcN-CPFXDTC would be a novel potential infection imaging agent.
Assuntos
Ciprofloxacina , Compostos de Organotecnécio , Compostos Radiofarmacêuticos , Tiocarbamatos/síntese química , Animais , Ciprofloxacina/análogos & derivados , Ciprofloxacina/sangue , Ciprofloxacina/síntese química , Ciprofloxacina/farmacocinética , Diagnóstico por Imagem , Masculino , Camundongos , Estrutura Molecular , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/síntese química , Compostos de Organotecnécio/farmacocinética , Tiocarbamatos/sangue , Tiocarbamatos/farmacocinética , Distribuição Tecidual , Contagem Corporal TotalRESUMO
OBJECTIVES: Imaging agents capable of providing cell compartment-specific information will facilitate studies of pathophysiological mechanisms, natural history of diseases, and therapeutic development. To demonstrate the effects of liver injury on the disposal of the organic anion mebrofenin, we performed animal studies. METHODS: Acute liver injury was induced in Fischer 344 rats with 0.25-1 ml/kg single doses of carbon tetrachloride followed by studies of animals over 4 weeks. The liver injury was analyzed by blood tests and histological grading. Additional rats were treated with lipopolysaccharide, interleukin-6 or tumor necrosis factor-alpha to activate inflammatory events. Hepatic clearance of Tc-mebrofenin was studied with dynamic imaging and fractional retention after 60 min of peak hepatic mebrofenin activity was determined. RESULTS: In healthy rats, only 24+/-2% of peak mebrofenin activity was retained in the liver after 60 min. By contrast, 24 h after carbon tetrachloride, virtually all mebrofenin activity was retained in the liver (P<0.001). Three weeks were required for mebrofenin excretion to become normal after carbon tetrachloride administration. In this situation, we found that Kupffer cell activity was increased. In addition, the abnormality in mebrofenin excretion was reproduced by lipopolysaccharide, which activates Kupffer cells. Moreover, mebrofenin excretion was highly sensitive to interleukin-6 and/or tumor necrosis factor-alpha, which help mediate the Kupffer cell response. CONCLUSION: Hepatobiliary excretion of mebrofenin was affected rapidly and over an extended period by inflammatory cytokines released after liver injury. The remarkable sensitivity of mebrofenin excretion to cytokines suggests that Tc-mebrofenin imaging will be helpful for assessing cytokine-mediated liver inflammation.
Assuntos
Iminoácidos/sangue , Iminoácidos/farmacocinética , Fatores Imunológicos/metabolismo , Fígado/metabolismo , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/farmacocinética , Compostos de Anilina , Animais , Citocinas , Glicina , Fígado/diagnóstico por imagem , Taxa de Depuração Metabólica , Cintilografia , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/farmacocinética , Ratos , Ratos Endogâmicos F344RESUMO
Mesothelin is a cell-surface glycoprotein restricted to mesothelial cells overexpressed in several types of cancer, including triple-negative breast cancer not responding to trastuzumab or hormone-based therapies. Mesothelin-targeting therapies are currently being developed. However, the identification of patients potentially eligible for such a therapeutic strategy remains challenging. The objective of this study was to perform the radiolabeling and preclinical evaluation of 99mTc-A1 and 99mTc-C6, two antimesothelin single-domain antibody (sdAb)-derived imaging agents. Methods: A1 and C6 were radiolabeled with 99mTc and evaluated in vitro on recombinant protein and cells, as well as in vivo in xenograft mouse models of the triple-negative breast cancer cell lines HCC70 (mesothelin-positive) and MDA-MB-231 (mesothelin-negative). Results: Both 99mTc-A1 and 99mTc-C6 bound mesothelin with high affinity in vitro, with 99mTc-A1 affinity being 2.4-fold higher than that of 99mTc-C6 (dissociation constant, 43.9 ± 4.0 vs. 107 ± 16 nM, P < 0.05). 99mTc-A1 and 99mTc-C6 remained stable in vivo in murine blood (>80% at 2 h) and ex vivo in human blood (>90% at 6 h). In vivo 99mTc-A1 uptake (percentage injected dose) in HCC70 tumors was 5-fold higher than in MDA-MB-231 tumors and 1.5-fold higher than that of 99mTc-C6 (2.34% ± 0.36% vs. 0.48% ± 0.18% and 1.56% ± 0.43%, respectively, P < 0.01) and resulted in elevated tumor-to-background ratios. In vivo competition experiments demonstrated the specificity of 99mTc-A1 uptake in HCC70 tumors. Conclusion: Mesothelin-positive tumors were successfully identified by SPECT using 99mTc-A1 and 99mTc-C6. Considering its superior characteristics, 99mTc-A1 was selected as the most suitable tool for further clinical translation.
Assuntos
Proteínas Ligadas por GPI/metabolismo , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Neoplasias de Mama Triplo Negativas/diagnóstico por imagem , Animais , Linhagem Celular Tumoral , Transformação Celular Neoplásica , Feminino , Humanos , Interações Hidrofóbicas e Hidrofílicas , Marcação por Isótopo , Ligantes , Mesotelina , Camundongos , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/química , Compostos de Organotecnécio/farmacocinética , Distribuição Tecidual , Neoplasias de Mama Triplo Negativas/patologiaRESUMO
Due to high expression of CXCR4 (CXC chemokine receptor type 4) receptors in many tumors and metastasis, synthesis and labeling of CXCR4 receptor-targeted analogs as tumor imaging agents have been encouraged. Herein, CXCR4 receptor-targeted peptide antagonist was prepared and thereafter its labeling with 99mTc by a bifunctional chelating agent and tricine coligand was developed. Radiotracer purity, stability, and tumor cell binding were assessed. Bioevaluation of radiotracer was performed in mice bearing xenograft tumor. More than 95% labeling yield and stability up to 24 hours were observed. Radiotracer-related tumor accumulation was 3.61 ± 0.15% ID/g at 1 hour postinjection. High stability and specific tumor uptake are important characteristics of the radiotracer that could nominate this as a targeted imaging agent in the future.
Assuntos
Compostos de Organotecnécio/síntese química , Compostos Radiofarmacêuticos/síntese química , Receptores CXCR4/antagonistas & inibidores , Animais , Estabilidade de Medicamentos , Xenoenxertos , Humanos , Melanoma Experimental/diagnóstico por imagem , Melanoma Experimental/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Nus , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/farmacocinética , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/farmacocinéticaRESUMO
Myocardial blood flow (MBF) and myocardial flow reserve (MFR) measured with PET have clinical value. SPECT cameras with solid-state detectors can obtain dynamic images for measurement of MBF and MFR. In this study, SPECT measurements of MBF made using 99mTc-tetrofosmin were compared with PET in the same patients. Methods: Thirty-one patients underwent PET MBF rest-stress studies performed with 82Rb or 13N-ammonia within 1 mo of their SPECT study. Dynamic rest-stress measurements were made using a SPECT camera. Kinetic parameters were calculated using a 1-tissue-compartment model and converted to MBF and MFR. Processing with and without corrections for attenuation (+AC and -AC), patient body motion (+MC and -MC), and binding of the tracer to red blood cells (+BB and -BB) was evaluated. Results: Both +BB and +MC improved the accuracy and precision of global SPECT MBF compared with PET MBF, resulting in an average difference of 0.06 ± 0.37 mL/min/g. Global MBF and detection of abnormal MFR were not significantly improved with +AC. Global SPECT MFR with +MC and +BB had an area under the receiver-operating curve of 0.90 (+AC) to 0.95 (-AC) for detecting abnormal PET MFR less than 2.0. Regional analysis produced similar results with an area under the receiver-operating curve of 0.84 (+AC) to 0.87 (-AC). Conclusion: Solid-state SPECT provides global MBF and MFR measurements that differ from PET by 2% ± 32% (MBF) and 2% ± 28% (MFR).
Assuntos
Imagem de Perfusão do Miocárdio/métodos , Tomografia por Emissão de Pósitrons/métodos , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Idoso , Idoso de 80 Anos ou mais , Doença da Artéria Coronariana/diagnóstico por imagem , Circulação Coronária , Eritrócitos/metabolismo , Feminino , Reserva Fracionada de Fluxo Miocárdico , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Pessoa de Meia-Idade , Compostos Organofosforados/sangue , Compostos de Organotecnécio/sangue , Curva ROC , Compostos Radiofarmacêuticos/sangue , Tecnécio Tc 99m SestamibiRESUMO
BACKGROUND: A simplified method of (99m)Tc-HEPIDA clearance determination, both plasma and hepatic, depends upon measuring the radiopharmaceutical concentration in plasma of a blood sample taken once in the time range from 68-83 min after injection of compound, and measurement of activity voided (excreted) with urine about five minutes after blood sampling. The aim of the present study was to analyze the clinical usefulness of both clearances, as determined by the simplified method in view of the diagnostic usefulness of both clearances (particularly of hepatic clearance) as determined by the respective multisampling method. MATERIAL AND METHODS: For the analysis, archived data of studies in 134 individuals (48 healthy individuals and 86 patients with chronic liver parenchyma damage) were used, in which plasma clearance (Cl(Pl)) and hepatic clearance (Cl(Hp)) (99m)Tc -HEPIDA were determined by the standard multisample method--the values of such determined clearances constituted clearance referential values for further comparative analyses. The clearances Cl(Pl) and Cl(Hp) were determined by the simplified method separately for three blood sampling times of: 60, 75 and 90 min, using the same archived data for calculation of corresponding concentrations of (99m)Tc-HEPIDA in plasma. For urinary clearances--which were necessary for calculation of Cl(Hp)--archived data were utilized on activity contained in voided urine (at about 95 min.). The clinical reference system used here was the semi-quantitative assessment of liver function, performed on the basis of commonly used basic biochemical indices (AST, ALT, GGTP, bilirubin, albumin and gammaglobulin in serum, proteinogram and prothrombin index). For each test there were 4 categories of results (sub-ranges) selected, which were ranked from 0 to 3. For each patient the ranks for the results of each test were summed, giving a total sum (called SP). These latter sums of ranks served as a reference system, characterizing liver condition (performance) in each individual. RESULTS: Clearance, Cl(Pl) and Cl(Hp), values, obtained by a simplified method, were correlated with respective values determined by the multisampling method, and with ranks (SP) representing classification of degree of hepatic parenchyma damage--SP. On the basis of the attribute independence Chi(2) test, the coherence of clearances (simplified determination) with SP was assessed. Also, analysis of variance of SP-values and clearance was performed using Spearman's theory for testing the correlation of non-continuous variables. By factorial analysis a factor responsible for changes in individual quantities (results of biochemical tests and (99m)Tc-HEPIDA clearances) was computed. Its loading was determined for each individual quantity. During analysis for each moment of blood sampling tight correlations of clearance values, obtained by the simplified method, were determined with referential values. The closest correlation was obtained for blood sampling at 75 min. It was found that there are negative correlations between values of hepatic and plasmatic clearances and SP. The values of r obtained for Cl(Hp) are close to those obtained for analogical correlations by multisampling methods. However, the values of correlation coefficient obtained for Cl(Pl) by single sample method are greater than those for Cl(Pl) determined by multisampling method. CONCLUSIONS: Factor loading, known as "liver incapacity", is greater for Cl(Hp) determined by single sample method, but lower than comparable hepatic clearance loading determined by the multi-sample procedure. Values of incapacity factor for Cl(Pl) are lower than for Cl(Hp), but the lowest value was obtained for Cl(Pl) determined by the multisampling method. Obtained values Chi(2), r and loading of incapacity factor speak in favour of the correlations between the degree of hepatic parenchyma performance and the values of clearances determined by the simplified method. However, this correlation is closer for Cl(Hp) than for Cl(Pl). In view of such a distinct correlation, there is good justification for the implementation of the simplified method for the determination of hepatic clearances used in diagnostic analysis of hepatic performance.
Assuntos
Iminoácidos/farmacocinética , Hepatopatias/diagnóstico por imagem , Hepatopatias/metabolismo , Fígado/diagnóstico por imagem , Fígado/metabolismo , Compostos de Organotecnécio/farmacocinética , Testes de Função Respiratória/métodos , Adulto , Feminino , Humanos , Interpretação de Imagem Assistida por Computador/métodos , Iminoácidos/sangue , Hepatopatias/sangue , Masculino , Taxa de Depuração Metabólica , Pessoa de Meia-Idade , Compostos de Organotecnécio/sangue , Cintilografia , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/metabolismoRESUMO
OBJECTIVE: To confirm the pharmacokinetics and biodistribution of 99mTc aprotinin in normal volunteers and to determine the optimum time for scanning post-injection, prior to further investigations of 99mTc aprotinin as an imaging agent for amyloidosis. METHODS: Five patients (three men and two women, average age 49 years, age range 38-66 years) without a history of amyloidosis or any of the associated diseases, were included in this prospective study. Blood and urine were collected and images were performed of the whole body and wrists. CONCLUSIONS: Normal biodistribution of 99mTc aprotinin includes early cardiac and lung activity in the blood pool phase with subsequent hepatic activity and renal excretion with variable splenic activity. There is variable bowel uptake on later images. The best quality images were obtained 90 min post-intravenous administration, and this is likely to be the optimum time for clinical imaging.
Assuntos
Aprotinina/farmacocinética , Compostos de Organotecnécio/farmacocinética , Adulto , Idoso , Aprotinina/sangue , Aprotinina/urina , Feminino , Humanos , Masculino , Taxa de Depuração Metabólica , Pessoa de Meia-Idade , Especificidade de Órgãos , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/urina , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/farmacocinética , Compostos Radiofarmacêuticos/urina , Valores de Referência , Distribuição TecidualRESUMO
The cartilage-targeting strategy is based on the strong affinity of quaternary ammonium (QA) functions for cartilage proteoglycans. We use a bifunctional agent containing QA moiety and a polyazamacrocycle structure able to complex technetium-99m. (99m)Tc-NTP 15-5 was selected for its high stability and its high affinity for proteoglycans in vivo. Labeling conditions of NTP 15-5 were optimized, and a lyophilized kit was developed for radiolabeling of (99m)Tc-NTP 15-5 (radiochemical yields 94.6±1.8%). (99m)Tc-NTP 15-5 was stable and resulted in favorable biological evaluations.
Assuntos
Cartilagem/diagnóstico por imagem , Cartilagem/metabolismo , Compostos Heterocíclicos com 1 Anel/isolamento & purificação , Compostos de Organotecnécio/isolamento & purificação , Proteoglicanas/metabolismo , Compostos de Amônio Quaternário/isolamento & purificação , Compostos Radiofarmacêuticos/isolamento & purificação , Tecnécio/isolamento & purificação , Animais , Doenças das Cartilagens/diagnóstico por imagem , Doenças das Cartilagens/metabolismo , Química Farmacêutica , Liofilização/métodos , Compostos Heterocíclicos com 1 Anel/sangue , Compostos Heterocíclicos com 1 Anel/farmacocinética , Indicadores e Reagentes , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/farmacocinética , Compostos de Amônio Quaternário/sangue , Compostos de Amônio Quaternário/farmacocinética , Cintilografia , Compostos Radiofarmacêuticos/sangue , Compostos Radiofarmacêuticos/farmacocinética , Ratos , Tecnécio/sangue , Tecnécio/farmacocinéticaRESUMO
Blood-brain barrier (BBB) passage of the flow tracer ethylenediylbis-L-cystein diethylester (bicisate, ECD) was measured repeatedly in five patients by means of the intravenous (i.v.) double-indicator technique using 24Na+ as an intravascular cotracer. After i.v. injection, the arterial concentration curve of 99mTc-bicisate was delayed and dispersed compared with that of the intravascular cotracer, presumably due to lung retention of the flow tracer. The corrected cerebral venous output curves were fitted using a three-compartment model with four parameters. At resting cerebral blood flow (CBF) values, the unidirectional brain extraction was 0.57 +/- 0.05, the permeability-surface area product for passage from blood to brain (PS1) was 0.48 +/- 0.07 ml/g/min, and the distribution volume for bicisate was 0.74 +/- 0.20 (mean +/- SD). In a single patient, BBB transport after i.v. injection of bicisate was compared with that of a similar flow tracer, d,l-hexamethylpropyleneamine oxime (HM-PAO), and similar values were found for the two tracers. In 19 rats, the brain extraction of bicisate was measured by means of the intracarotid double-indicator technique. The brain extraction was measured at resting, decreased, and increased CBF values. Low CBF values were obtained by hyperventilation and high values by hypercapnia. The degree of backflux of tracer from brain to blood was evaluated by means of the three-compartment model and was found to be negligible in these experiments. The brain extraction was 0.70 +/- 0.1 and PS1 was 0.94 +/- 0.27 ml/g/min. During hypercapnia, CBF increased from 0.77 to 1.09 ml/g/min, leading to a significant decrease in brain extraction, from 0.70 to 0.56.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Encéfalo/metabolismo , Cisteína/análogos & derivados , Compostos de Organotecnécio/farmacocinética , Adulto , Animais , Artérias , Transporte Biológico , Barreira Hematoencefálica , Circulação Cerebrovascular , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Compostos de Organotecnécio/sangue , Compostos de Organotecnécio/química , Oximas/farmacocinética , Ratos , Ratos Wistar , Radioisótopos de Sódio , Distribuição Tecidual , VeiasRESUMO
The isolated perfused rat heart preparation was used to determine whether the interaction of blood with either 99mTc-teboroxime, 99mTc-sestamibi or 201TI affects the extraction of these myocardial perfusion agents. Hearts were retrogradely perfused at 72 cm H2O with Krebs-Henseleit buffer equilibrated with O2:CO2 (95:5). The hearts were paced at 5 Hz. Single-pass extraction of 99mTc-teboroxime (96% +/- 1%) was greater than that of 99mTc-sestamibi (15% +/- 1%) or 201TI (30% +/- 5%). Extraction of the hydroxide form of 99mTc-teboroxime was only 43% +/- 4%. When arterial blood obtained from rats administered 99mTc-teboroxime was injected into the perfused heart, extraction of 99mTc-teboroxime decreased progressively as its time in circulation was lengthened. Similar experiments using either 99mTc-sestamibi or 201TI showed that extraction of these agents was neither affected by the presence of blood nor residence in circulation. For 99mTc-teboroxime, extraction was 99.5% +/- 0.5%, 57% +/- 13%, 20% +/- 2% at 1, 5, and 60 min postinjection, respectively. In separate experiments, HPLC analysis of blood at 5, 15 and 60 min postinjection indicated that only 34% +/- 4%, 13% +/- 2%, and 2% +/- 1%, respectively, of the total 99mTc-teboroxime was free and was associated with extraction values of 44% +/- 7%, 28% +/- 5%, and 19% +/- 3%, respectively. The percentage of this free radioactivity that converted from the chloro to the hydroxide form was 9% +/- 2%, 6% +/- 2%, and 2% +/- 1%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Miocárdio/metabolismo , Compostos de Organotecnécio/farmacocinética , Oximas/farmacocinética , Animais , Circulação Coronária , Masculino , Compostos de Organotecnécio/sangue , Oximas/sangue , Perfusão , Ratos , Ratos Endogâmicos , Tecnécio Tc 99m Sestamibi , Radioisótopos de Tálio/sangue , Radioisótopos de Tálio/farmacocinética , Fatores de TempoRESUMO
L,L-ethylenedicysteine (L,L-EC) can be labeled efficiently with 99mTc at pH 12 to obtain a highly pure and very stable tracer agent (99mTc-L,L-EC). The biological behavior of 99mTc-L,L-EC was studied in mice and a baboon. In mice, 99mTc-L,L-EC demonstrated a more rapid urinary excretion and less retention in the kidneys, the liver, the intestines, and the blood than did 99mTc-MAG3 at 10 and 60 min p.i. Urinary excretion decreased in probenecid pretreated mice, which indicates active tubular transport. In the baboon, the renograms for 99mTc-MAG3 and 99mTc-L,L-EC were comparable. Plasma-protein binding of 99mTc-L,L-EC was lower than that of 99mTc-MAG3 while its distribution volume and 1-hr plasma clearance were clearly higher. The promising results of the animal experiments suggest that 99mTc-L,L-ethylenedicysteine may be a useful alternative to 99mTc-MAG3 for renal function studies in humans.
Assuntos
Cisteína/análogos & derivados , Compostos de Organotecnécio/farmacocinética , Renografia por Radioisótopo , Animais , Cisteína/sangue , Cisteína/farmacocinética , Avaliação de Medicamentos , Marcação por Isótopo , Masculino , Camundongos , Oligopeptídeos , Compostos de Organotecnécio/sangue , Papio , Tecnécio Tc 99m Mertiatida , Distribuição TecidualRESUMO
Technetium-99m mercaptoacetyltriglycine (MAG3) clearance is strongly correlated with effective renal plasma flow and can be used directly as a measure of renal function. For these reasons, formulas were developed for estimation of [99mTc]MAG3 clearance based on one or two plasma samples. A two-exponential model provided an excellent fit for 8-point plasma clearance curves obtained from 35 patients having a wide range of renal function. The 8-point [99mTc]MAG3 clearance could be estimated from a single point at 43 min with an error of 19 ml/min (residual s.d.) or from two samples at 12 and 94 min with an error of 7 ml/min. The relative errors with MAG3 are thus comparable to those reported for similar techniques used with [131I]orthoiodohippurate, [99mTc]diethylenetriaminepentraacetic acid and [51Cr]ethylenediaminetetraacetic acid.
Assuntos
Nefropatias/diagnóstico por imagem , Oligopeptídeos/metabolismo , Compostos de Organotecnécio/metabolismo , Renografia por Radioisótopo , Adulto , Humanos , Nefropatias/fisiopatologia , Oligopeptídeos/sangue , Compostos de Organotecnécio/sangue , Tecnécio Tc 99m MertiatidaRESUMO
Dynamic renal scintigraphy using technetium-99m mercaptoacetylglycylglycylglycine (MAG3) has been described in adults, and clearance values have been established using multiple plasma samples. This study of renal clearance has compared two fundamentally different gamma camera techniques (both of which require a single blood sample) with the multiple blood sampling technique in children (n = 30). Results show that a 40-min dynamic 99mTc-MAG3 renal scintigram coupled with a single plasma sample will allow analysis of the data so that clearance values, which are similar to those from multiple plasma samples, may be calculated. The curve generated from the cardiac region of interest (ROI) provided clearances values that had a high correlation coefficient (0.939-0.951) compared to the multiple-plasma sample technique immaterial of the timing of the blood sample. The renal uptake method of clearance had a lower correlation coefficient (0.89-0.92), which varied with the timing of the blood sample compared to the multiple-plasma sampling technique. This study has demonstrated that an extended gamma camera acquisition coupled with a single-plasma sample may be used for quantitative renal function studies using 99mTc-MAG3.
Assuntos
Rim/metabolismo , Oligopeptídeos/farmacocinética , Compostos de Organotecnécio/farmacocinética , Renografia por Radioisótopo/métodos , Adolescente , Criança , Pré-Escolar , Feminino , Câmaras gama , Humanos , Masculino , Taxa de Depuração Metabólica , Oligopeptídeos/sangue , Compostos de Organotecnécio/sangue , Tecnécio Tc 99m MertiatidaRESUMO
UNLABELLED: The purpose of the current study was to determine whether teboroxime clearance kinetics are useful in differentiating the severity of coronary artery flow restriction. METHODS: Groups of dogs received stenoses of the left circumflex coronary artery as follows: nine dogs received a mild-to-moderate stenosis (Group 2) and eleven dogs received severe stenoses (Group 3). In three control dogs (Group 1), there was no stenosis. Using miniature cadmium-telluride radiation detectors, myocardial teboroxime activities were continuously monitored in both the control and stenosed zones following dipyridamole infusion. RESULTS: A significant difference in fractional myocardial clearance between the control zones (0.69 +/- 0.01, n = 26) versus mild-to-moderate (0.61 +/- 0.06, p < 0.05, n = 9) and severe (0.57 +/- 0.03, p < 0.01 versus control, p < 0.05 versus mild-to-moderate, n = 11) flow-restricted zones was observed over a 1-hr period. Significant differences between normal and both stenosed zones became apparent after 7 min of clearance. Significant differences in myocardial clearance between mild-to-moderate and severe groups were detected within 15 min. CONCLUSION: Thus, in this canine model using dipyridamole, miniature probe-determined teboroxime myocardial clearance can differentiate among normal myocardium, myocardium distal to a mild-to-moderate stenosis and myocardium distal to a severe stenosis.
Assuntos
Doença das Coronárias/diagnóstico por imagem , Dipiridamol , Miocárdio/metabolismo , Compostos de Organotecnécio/farmacocinética , Oximas/farmacocinética , Animais , Circulação Coronária , Doença das Coronárias/metabolismo , Doença das Coronárias/fisiopatologia , Modelos Animais de Doenças , Cães , Hemodinâmica , Compostos de Organotecnécio/sangue , Oximas/sangue , CintilografiaRESUMO
UNLABELLED: (99m)Tc-[bis (dimethoxypropylphosphinoethyl)-ethoxyethylamine (PNP5)]-[bis (N-ethoxyethyl)-dithiocarbamato (DBODC)] nitride (N-PNP5-DBODC or N-DBODC5) is a new monocationic myocardial perfusion tracer. We sought to compare the myocardial uptake and clearance kinetics and organ biodistribution of (99m)Tc-N-DBODC5 with (99m)Tc-sestamibi and (99m)Tc-tetrofosmin. METHODS: Seventy-five anesthetized Sprague-Dawley rats were injected intravenously with 22.2-29.6 MBq (99m)Tc-N-DBODC5 (n = 25), (99m)Tc-sestamibi (n = 25), or (99m)Tc-tetrofosmin (n = 25). Rats were euthanized at either 2, 10, 20, 30, or 60 min after injection and gamma-well counting was performed on excised organ (heart, lung, and liver) and blood samples. In 3 additional rats, serial in vivo whole-body gamma-camera imaging with each tracer was performed. RESULTS: (99m)Tc-N-DBODC5 cleared rapidly from the blood pool. At 2 min after injection, (99m)Tc-N-DBODC5 blood activity was significantly lower than either (99m)Tc-sestamibi or (99m)Tc-tetrofosmin (P < 0.01) and remained lower over 60 min. Myocardial (99m)Tc-N-DBODC5 uptake was rapid (2.9% +/- 0.1% injected dose/g at 2 min), and there was no significant clearance over 60 min, similar to (99m)Tc-sestamibi and (99m)Tc-tetrofosmin. All 3 tracers exhibited rapid lung clearance. Importantly, (99m)Tc-N-DBODC5 cleared more rapidly from the liver than either (99m)Tc-sestamibi or (99m)Tc-tetrofosmin. As early as 30 min after injection, (99m)Tc-N-DBODC5 heart-to-liver ratio was 5.7 +/- 1.0 versus 1.6 +/- 0.1 and 2.9 +/- 0.3 for (99m)Tc-sestamibi and (99m)Tc-tetrofosmin (P < 0.05). By 60 min, (99m)Tc-N-DBODC5 heart-to-liver ratio further increased to 18.4 +/- 2.0 compared with 2.6 +/- 0.2 and 5.8 +/- 0.7 for (99m)Tc-sestamibi and (99m)Tc-tetrofosmin (P < 0.001). The rapid blood pool, lung, and liver clearance of (99m)Tc-N-DBODC5 resulted in excellent-quality myocardial images within 30 min after injection. CONCLUSION: (99m)Tc-N-DBODC5 is a promising new myocardial perfusion tracer with superior biodistribution properties. The rapid (99m)Tc-N-DBODC5 liver clearance may shorten the duration of imaging protocols by allowing earlier image acquisition and may markedly reduce the problem of photon scatter from the liver into the inferoapical wall on myocardial images.